Also trades as: COLO-B.CO (CPH) · $vol 22M · CBHD.DE (XETRA) · $vol 0M · CLPBF (OTC) · $vol 0M

$6.18

-0.08 (-1.28%)

Weekly Expected Move ±2.6%

$6 $6 $6 $6 $7

OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 32 · $13.9B mcap · 143M float · 0.239% daily turnover · Short 34% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$26.3B -2.9% ▼

5Y CAGR: +7.2%

Gross Profit

$17.1B -6.5% ▼

5Y CAGR: +6.3%

Operating Income

$7.1B -2.5% ▼

5Y CAGR: +4.0%

Net Income

$3.4B -32.2% ▼

5Y CAGR: -4.0%

EPS (Diluted)

$1.52 -32.4% ▼

5Y CAGR: -5.1%

EBITDA

$7.9B -7.4% ▼

5Y CAGR: +4.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.4B	$22.6B	$24.5B	$27.0B	$26.3B
YoY Growth	+4.8%	+16.2%	+8.5%	+10.3%	-2.9%
Cost of Revenue	$6.1B	$7.0B	$8.2B	$8.8B	$9.2B
Gross Profit	$13.3B	$15.5B	$16.3B	$18.3B	$17.1B
Gross Margin	68.5%	68.8%	66.6%	67.6%	65.1%
R&D Expenses	$755M	$866M	$872M	$913M	$848M
SG&A Expenses	$6.2B	$7.8B	$8.6B	$10.1B	$9.1B
Operating Expenses	$7.0B	$8.6B	$9.5B	$10.9B	$9.9B
Operating Income	$6.4B	$6.4B	$6.8B	$7.3B	$7.1B
Operating Margin	32.7%	28.5%	27.6%	27.1%	27.2%
Interest Expense	$25M	$172M	$638M	$882M	$777M
Income Before Tax	$6.2B	$6.1B	$6.0B	$6.4B	$5.8B
Tax Expense	$1.4B	$1.4B	$1.2B	$1.3B	$2.4B
Net Income	$4.8B	$4.7B	$4.8B	$5.1B	$3.4B
Net Margin	24.8%	20.8%	19.5%	18.7%	13.0%
EPS (Diluted)	$2.26	$2.21	$2.22	$2.25	$1.52
EBITDA	$7.1B	$7.2B	$7.7B	$8.5B	$7.9B
Shares Outstanding	2.13B	2.13B	2.15B	2.25B	2.25B

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$7.0B	$7.0B	$6.9B	$7.0B	$5.3B	$7.0B	$7.2B	$7.5B
Cost of Revenue	$2.3B	$2.3B	$2.2B	$2.3B	$2.2B	$2.3B	$4.1B	$2.5B
Gross Profit	$4.6B	$4.8B	$4.7B	$4.7B	$4.7B	$4.7B	$3.1B	$5.0B
Gross Margin	66.7%	67.6%	68.2%	67.6%	88.9%	66.6%	42.9%	66.7%
R&D Expenses	$219M	$219M	$239M	$239M	$248M	$245M	$258M	$286M
SG&A Expenses	$2.6B	$2.6B	$2.6B	$2.6B	$2.6B	$2.6B	$2.7B	$2.8B
Operating Expenses	$2.7B	$2.8B	$2.8B	$2.9B	$2.8B	$2.9B	$1.3B	$3.1B
Operating Income	$1.9B	$1.9B	$1.9B	$1.8B	$1.9B	$1.9B	$1.8B	$1.9B
Operating Margin	27.4%	27.2%	27.3%	26.3%	35.8%	26.3%	25.4%	25.9%
Interest Expense	$219M	$204M	$316M	$490M	$183M	$164M	$137M	$196M
Income Before Tax	$1.6B	$1.8B	$1.5B	$1.3B	$1.2B	$1.8B	-$1.3B	$1.9B
Tax Expense	$289M	$725M	$579M	$537M	-$9.3B	$394M	-$278M	$419M
Net Income	$1.3B	$1.0B	$912M	$805M	$872M	$1.4B	-$987M	$1.5B
Net Margin	18.9%	14.9%	13.2%	11.6%	16.3%	19.7%	-13.7%	19.9%
EPS (Diluted)	$0.58	$0.46	$0.41	$0.36	$0.39	$0.61	$-0.44	$0.65
EBITDA	$2.1B	$2.3B	$2.2B	$2.2B	$2.2B	$2.3B	$5.2B	$2.3B
Shares Outstanding	2.25B	2.25B	2.25B	2.25B	2.25B	2.25B	2.25B	2.25B

CLPBY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet